People with multiple myeloma, a blood malignancy of plasma cells in the bone marrow, have a poorer overall survival rate when compared to individuals without diabetes. This difference in survival due to diabetes was found in white patients in a subgroup analysis but not in black patients, ac
When compared to people without diabetes, those with multiple myeloma, a blood malignancy of plasma cells in the bone marrow, have a worse overall survival rate. According to a study published today in Blood Advances, this difference in survival related to diabetes was detected in white pati
Washington DC [USA], Dec 30 (ANI): A study has recently found that taking a higher dose of Carfilzomib, which is used for treating cancer, can increase the risk of hypertension, heart failure, and heart attacks in multiple myeloma patients.